Farmas USA

Esa se va a 5,50 antes que a 5,05

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) No. 2 Among Top Five Biotechnology Stocks of 2012 – (THLD, BDSI, OMER, GALE)

http://www.pt-news.org/arena-pharmaceuticals-inc-nasdaqarna-no-2-among-top-five-biotechnology-stocks-of-2012-thld-bdsi-omer-gale/124221/

This year, Threshold Pharmaceuticals, Inc (NASDAQ:THLD) is the one of the leading top performers with a year-to-date performance of 461.48%. The stock, as of last close, traded 480.51% up from its 52 week low and was 24.48% behind its 52 week high. Its latest closing price was 6.85% above the SMA20 while the distance from SMA 50 and SMA 20 was 3.77% and 2.60% respectively. THLD a development stage company, focuses on the discovery and development of drugs for the microenvironment of solid tumors and the bone marrows of hematologic malignancies as novel treatments for patients living with cancer.
The second best stock Arena Pharmaceuticals, Inc (NASDAQ:ARNA) is a clinical-stage biopharmaceutical company, engaged in the discovering, developing, and commercializing oral drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena Pharmaceuticals, Inc has performance up at 428.34%. Its price, as of the latest close, was up 703.25% compared with the 52 week low and was 15.63% below the 52 week high. The stock’s latest closing price was 3.44% up from an average-price of 20 days while it kept its distance from SMA 50 at +90.19% and +31.03% compared with SMA 20.
BioDelivery Sciences International, Inc (NASDAQ:BDSI) so far this year moved up 398.77% and its monthly performance stands at -2.42%. The stock was 424.68% down compared with the 52 week low and was 11.01% below the 52 week high. Its latest closing price was 4.04% up from an average-price of 20 days while it kept its distance from SMA 50 at +9.94% and +14.42% compared with SMA 20. BioDelivery Sciences is a specialty pharmaceutical company, focusing on developing and commercializing therapeutics in the areas of pain management and oncology supportive care.
Omeros Corporation (NASDAQ:OMER) a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system. Omeros Corporation has shown an uptrend of 235.44% this year with a monthly performance of 33.57% and 3-month performance up 35.48%. Its latest closing price was 13.25% up from an average-price of 20 days while it maintained a distance from the SMA 50 at +30.66% and +15.62% compared with the SMA 20. The stock was up 319.30% compared with the 52 week low and was 0.30% above the 52 week high.
Year-to-date performance of Galena Biopharma Inc (NASDAQ:GALE) stands at 231.91% amid an advance of -30.97% in last three months and 59.18% in the previous twelve months. Its price, as of the latest close, was 333.33% up from the 52 week low and was 55.93% below the 52 week high. Its latest closing price was 1.56% up from an average-price of 20 days while it kept its distance from the SMA 50 at 13.62% and 17.29% compared with the SMA 20. Galena Biopharma is a biotechnology company, engages in discovering, developing, and commercializing innovative therapies addressing unmet medical needs using targeted biotherapeutics.
Disclosure: The views and opinions expressed in this article are exclusively those of the authors who have no stake in any stocks mentioned, and hold no plan to acquire any stake within the next 5 days.
 
 

Se os va a escapar del todo CLSN hoy lleva otro 4,5% de subida...

entre a 2,57 y esta a 2,92. Se va a 3 antes de julio

Con tanta noticia repetida tengo la sensación de un continuo deja vú

:-D

puta, no te chives
;)

Framus ZLCS amigo esto no me alegra acabo de tocar los 2000 verdes en rojo que ironía jajaja verdes en rojo me pone de un nervioso porque no baja de poquito cada escalon es de 1 en uno, sabras porque es asi y no 1.3478 por ejemplo?

jajajaja.
joder a las DNDN como me las están atizando hoy.
Vendiste Achn????

Si con un valor como ZALICUS no aguantas un -30% sin sudar ni la mas minima gota .. malo, malo.
I AM LONG ZLCS